PCG Molecular Diagnostic Panels and Testing

Comprehensive Testing and Greater Diagnostics

PCG Molecular offers advanced diagnostic testing for Physicians, Clinicians, Health Care Facilities, and
Point of Care options for patients. Our goal is to provide practitioners with pliable business models, affordable tests for their patients, and easy to understand results and post-treatment recommendations. We are a 
 preventive care diagnostic company driven to change the approach to health, from reactive care to proactive 
care. We are vested in the research and development of genetic, molecular screenings that detect health threats early, are non-invasive, and easy to administer to the patient.

Infectious Disease, Cancer, and Gastrointestinal pathogen 
Identification 

Infectious disease 

click on icons to learn more

Cancer

Gastrointestinal 

Cysto One PAP 1.0 - Urinary & Infectious Disease Panel

Screen Shot 2021-11-02 at 12.36.12 PM.png

The Cysto One PAP™ is a molecular test to screen and diagnose low and high grade urinary bladder malignancies as well as urinary tract infections and sexually transmitted diseases.

Screen Shot 2021-11-08 at 5.30_edited.pn
 

MOP ID 1.0 - Infectious Disease Panel

Screen Shot 2021-11-02 at 12.35.33 PM.png

The MOP ID ™ is a qualitative in vitro test for the detection of HPV, CT/NG, HSV1/2, Candida, Trichomonas and a quantitative test for HCV, HIV and HBV in specimens from the oral cavity. 

Screen Shot 2021-11-08 at 5.28_edited.pn

Bella One PAP 1.0 - Infectious Disease Panel

Screen Shot 2021-11-02 at 12.35.42 PM.png

The Bella One PAP is the first FDA-approved test to screen not only for 14 high-risk strains of HPV, but also for other sexually transmitted infections that pose a threat to women’s health.

AdobeStock_443554927_edited.png

The PCG Molecular® Respiratory 2.1 (RP2.1) Panel

AdobeStock_463622056_edited.png

Anal One PAP 1.0 - Cancer Test

AdobeStock_111986085_edited.png
Screen%20Shot%202020-11-06%20at%207_edit
Screen Shot 2021-11-08 at 4.59.16 PM.png

SARS-CoV-2 is a top concern for patients and clinicians, but several respiratory pathogens can cause nearly indistinguishable symptoms. The FDA De Novo authorized PCG Molecular RP2.1 Panel is a frontline test to help clinicians quickly diagnose respiratory infections, including COVID-19, influenza, RSV, and many others.

Anal One PAP 1.0 - Cancer Test

Screen Shot 2021-11-02 at 12.36.04 PM.png

The Anal One PAP™ not only shows whether you have anal cancer, but also if your in a higher risk category to contract it. It’s an innovative genetic test that screens for anal cancer and its risk factors in three ways.

Screen Shot 2021-11-08 at 5_edited_edite
 

The PCG Molecular® FilmArray® Gastrointestinal Panel

Screen%20Shot%202020-11-06%20at%207_edit
Screen Shot 2021-11-08 at 4.59.16 PM.png

The PCG Molecular GI Panel tests stool specimens for common pathogens associated with gastroenteritis. Quickly identifying the correct pathogen can ensure appropriate treatment, improve patient management, and help detect infectious gastroenteritis which can lead to severe illness or death.

AdobeStock_302423130_edited.png